Provide Current Location
Sign in to see your saved address

SUN PHARMA

Brimosun Ls Eye Drops (5 Ml)

₹ 218.40 / Piece

₹ 273

20%

Whatsapp
Facebook

⭐Important Notice⭐

* T & C Apply.
* Product MRP can be changed without prior notice.
* Product offer can be withdrawn, modified, and removed by the company without prior notice.
* Product images sometimes change based on stock availability.
* Delivery lead time can vary depending on traffic and availability.
* product availability as per location-wise stock matters.
* Please check the details of medicines Name, Strength, Quantity, Batch No., Expiry date, etc., with your prescription
Please understand that after accepting the medicines, we shall not be liable or responsible.
* Batch No., MRP, Expiry date, Image, description can be changed as per notice, etc.
* Any suppor,supportt please call/Whatsapp us ‪+91 8101099110‬.

Join WhatsApp Channel For Offer & Updates:-  https://whatsapp.com/channel/0029VagZBQk4yltHfZOmXQ0g

Brimosun LS Eye Drops (5 mL) - Trusted Care for Your Eyes

Brand: SUN PHARMA

Introducing Brimosun LS Eye Drops, a high-quality ophthalmic solution crafted by the renowned pharmaceutical brand, Sun Pharma. Designed to support your eye health, these eye drops are trusted by professionals and users alike for their effectiveness and reliability. Whether you're managing specific eye conditions or looking to soothe discomfort, Brimosun LS is here to provide relief.

Why Choose Brimosun LS Eye Drops?

  • Trusted Brand: Manufactured by Sun Pharma, a leader in pharmaceutical innovation and quality.
  • Precision Formulation: Carefully developed to address specific eye care needs with maximum efficacy.
  • Convenient 5 mL Packaging: Compact and easy-to-use, perfect for on-the-go or at-home care.

Important Notes:

  • Please verify medicine details, including name, strength, quantity, batch number, and expiry date, with your prescription before use.
  • Stock availability and delivery times may vary based on your location and other factors.
  • Product images are subject to change